Aktuality vo vede

V tejto sekcii nájdete výber článkov zo svetovej odbornej literatúry.


Guidelines ADA-EASD 2020

Autori:  Buse J, et al. Diabetologia 2020;43(2):487–493. Vydanie:  Aktualizácia konsenzu ADA-EASD priniesla nasledovné významné zmeny v manažmente hyperglykémie u pacientov s DM 2.typu a KV rizikom, srdcovým zlyhávaním (SZ) a chronickou obličkovou chorobou (CKD).
pridal plasil.r_1668 dňa 26. október 2020 - 19:17

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Autori:  M. Packer, S.D. Anker, J. Butler, G. Filippatos, S.J. Pocock, P. Carson, J. Januzzi, S. Verma, H. Tsutsui, M. Brueckmann, W. Jamal, K. Kimura, J. Schnee, C. Zeller, D. Cotton, E. Bocchi, M. Böhm, D.-J. Choi, V. Chopra, E. Chuquiure, N. Giannetti, S. Janssens, J. Zhang, J.R. Gonzalez Juanatey, S. Kaul, H.-P. Brunner-La Rocca, B. Merkely, S.J. Nicholls, S. Perrone, I. Pina, P. Ponikowski, N. Sattar, M. Senni, M.-F. Seronde, J. Spinar, I. Squire, S. Taddei, C. Wanner, and F. Zannad, for the EMPEROR-Reduced Trial Investigators Zdroj:  The NEW ENGLAND JOURNAL of MEDICINE
pridal plasil.r_1668 dňa 22. september 2020 - 12:08

FOURIER trial: Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction

Autori:  Baris Gencer, MD; François Mach, MD; Sabina A. Murphy, MPH; Gaetano M. De Ferrari, MD; Kurt Huber, MD; Basil S. Lewis, MD; Jorge Ferreira, MD; Christopher E. Kurtz, MD; Huei Wang, PhD; Narimon Honarpour, MD; Anthony C. Keech, MD; Peter S. Sever, MD; Terje R. Pedersen, MD; Marc S. Sabatine, MD, MPH; Robert P. Giugliano, MD, SM Zdroj:  Journal of the American College of Cardiology
pridal plasil.r_1668 dňa 11. august 2020 - 15:20

Intrahepatic Fat and Postprandial Glycemia Increase After Consumption of a Diet Enriched in Saturated Fat Compared With Free Sugars

Autori:  Siôn A. Parry1, Fredrik Rosqvist1,2, Ferenc E. Mozes3, Thomas Cornfield1, Matthew Hutchinson1, Marie-Eve Piche1,4, Andreas J. Hülsmeier5, Thorsten Hornemann5, Pamela Dyson1,6 and Leanne Hodson1,6 Zdroj:  Diabetes Care Vydanie:  Diabetes Care 2020 May; 43(5): 1134-1141
pridal plasil.r_1668 dňa 17. máj 2020 - 16:12

Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up

Autori:  Peter D. Reaven, M.D., Nicholas V. Emanuele, M.D., Wyndy L. Wiitala, Ph.D., Gideon D. Bahn, Ph.D., Domenic J. Reda, Ph.D., Madeline McCarren, Ph.D., William C. Duckworth, M.D., and Rodney A. Hayward, M.D. for the VADT Investigators, N Engl J Med 2019; 380:2215-2224, DOI: 10.1056/NEJMoa1806802, June 6, 2019 Zdroj:  The NEW ENGLAND JOURNAL of MEDICINE
pridal plasil.r_1668 dňa 17. máj 2020 - 16:02

Switching to iGlarLixi Versus ContinuingDailyorWeeklyGLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial

Autori:  Lawrence Blonde,1 Julio Rosenstock,2 Stefano Del Prato,3 Robert Henry,4 Naim Shehadeh,5 Juan Frias,6 Elisabeth Niemoeller,7 Elisabeth Souhami,8 Chen Ji,9 and Vanita R. Aroda10 Zdroj:  Diabetes Care
pridal plasil.r_1668 dňa 12. december 2019 - 10:49

2019 ESC Guidelines on Dyslipidaemias

Autori:  François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference, Ian M Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R Pedersen, Gabriele Riccardi, Dimitrios J Richter, Marc S Sabatine, Marja-Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, ESC Scientific Document Group European Heart Journal, ehz455, https://doi.org/10.1093/eurheartj/ehz455 Published: 31 August 2019
pridal plasil.r_1668 dňa 9. december 2019 - 13:34

Alirokumab a kardiovaskulárne výsledky po akútnom koronárnom syndróme

Autori:  Gregory G. Schwartz, M.D., Ph.D., P. Gabriel Steg, M.D., Michael Szarek, Ph.D., Deepak L. Bhatt, M.D., M.P.H., Vera A. Bittner, M.D., M.S.P.H., Rafael Diaz, M.D., Jay M. Edelberg, M.D., Ph.D., Shaun G. Goodman, M.D., Corinne Hanotin, M.D., Robert A. Harrington, M.D., J. Wouter Jukema, M.D., Ph.D., Guillaume Lecorps, M.Sc., et al., for the ODYSSEY OUTCOMES Committees and Investigators* Zdroj:  The NEW ENGLAND JOURNAL of MEDICINE
pridal plasil.r_1668 dňa 30. november 2019 - 18:58

SGLT2 inhibition and heart failure - current concepts

Autori:  Joaquim Silva Custodio Jr1,2 & Andre Rodrigues Duraes1,3 & Marconi Abreu4 & Natalia Albuquerque Rocha4 & Leonardo Roever5 # Springer Science+Business Media, LLC, part of Springer Nature 2018
pridal plasil.r_1668 dňa 19. september 2019 - 8:15

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (Credence)

Autori:  V. Perkovic, M.J. Jardine, B. Neal, S. Bompoint, H.J.L. Heerspink, D.M. Charytan, R. Edwards, R. Agarwal, G. Bakris, S. Bull, C.P. Cannon, G. Capuano, P.-L. Chu, D. de Zeeuw, T. Greene, A. Levin, C. Pollock, D.C. Wheeler, Y. Yavin, H. Zhang, B. Zinman, G. Meininger, B.M. Brenner, and K.W. Mahaffey, for the CREDENCE Trial Investigators ** This article was published on April 14, 2019, at NEJM.org. DOI: 10.1056/NEJMoa1811744 Zdroj:  The NEW ENGLAND JOURNAL of MEDICINE
pridal plasil.r_1668 dňa 23. máj 2019 - 14:37

Stránky